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ABSTRACT
Purpose: Anecdotal evidence suggests that
eyelid disorders are common, although esti-
mates of prevalence vary. The current study
determines the prevalence of eyelid disorders,
meibomian gland dysfunction (MGD) and
related diseases (specifically ocular surface dis-
ease) in a population of patients presenting for
routine ophthalmologic consultations.
Methods: This cross-sectional epidemiologic
survey evaluated patients presenting for routine
ophthalmic visits. During the consultation an
ophthalmologist completed a questionnaire,
and each patient underwent an ophthalmic
examination and completed a quality of life
questionnaire.
Results: Three hundred forty-nine ophthal-
mologists, recruited from 11 countries, pro-
vided data on 6525 patients. Patients were
predominantly females (61.6%). The mean age
of the study population was 57.0 ± 17.6 years.
Eyelid disorders were diagnosed in 5109 (78.3%)
patients and were statistically associated with:
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atopic dermatitis, seborrheic dermatitis, dry eye,
age-related macular degeneration, diabetes,
cataract, allergy and MGD (P\0.05, all associ-
ations). Eyelid abnormalities were identified in
59.6% of patients; conjunctival or corneal
abnormalities were observed in 64.9% and
28.1% of patients, respectively. MGD was diag-
nosed in 54.3% patients and was statistically
significantly associated with the presence of
eyelid disorders and eyelid margin abnormali-
ties (P\0.001, both comparisons). Dry eye was
diagnosed in 61.8% of patients. Concurrent dry
eye and MGD were present in 67.6% of patients.
Most patients reported some degree of impaired
vision and daily/work activities related to dry
eye. Impact on contact lens usage, emotions
and quality of sleep was also reported. The
effects on daily life were associated with the
presence of MGD.
Conclusion: In conclusion, eyelid disorders
were highly prevalent in this ‘real-world’ pop-
ulation of patients from ophthalmology clinics.
Routine ophthalmologic consultations provide
an opportunity to improve patient quality of
life and to modify topical therapy in patients
who may be predisposed to eyelid disorders.
Keywords: Blepharitis; Dry eye; Eyelid
disorders; Meibomian gland disorder; Ocular
surface disease
Key Summary Points
Why carry out this study?
Anecdotal evidence and clinical
experience suggest that eyelid disorders
are common in daily clinical practice.
However, multicenter international
studies of prevalence are rare.
This study evaluated the prevalence of
eyelid disorders in a ‘real-world’ European
multicenter trial.
What was learned from the study?
Among patients present for routine
ophthalmic visits, the prevalence of MGD
was 54% (data).
The high prevalence of MGD and
associated ocular surface disorders
indicates that these disorders may be
underdiagnosed and the majority of
routine ophthalmic patients may require
assessment for ocular surface disease.
Timely treatment of ocular surface disease
and eyelid disorders may improve
compliance with topical therapy for other
ophthalmic conditions.
INTRODUCTION
The etiology of dry eye is multifactorial and
involves a dysfunctional lacrimal system [1–4].
Meibomian gland dysfunction (MGD) is the
most common cause of dry eye disease, and the
interactions between these two conditions have
been described as a ‘vicious cycle’ that causes
tear film instability (due to MGD) leading to
hyperosmolarity and inflammation that is
characteristic of dry eye disease, which in turn
promotes further MGD [5]. The lipid and pro-
tein secretions from the meibomian glands are
critical in maintaining the tear film by miti-
gating evaporation and dryness [6]. The rela-
tionship between MGD and dry eye has been
well documented in the literature [3, 4].
Dry eye can significantly impair quality of
life by interfering with daily living activities and
work [7, 8]. Dry eye represents a significant
proportion of any ophthalmic practice, yet the
real prevalence remains ambiguous because of
methodologic techniques [9, 10]. Similarly,
MGD appears to be a common ophthalmic
condition. The International Workshop on
MGD reported a wide range of prevalence from
population-based studies depending on
methodology and ethnicity [11]. Studies per-
formed in clinical ophthalmic settings generally
reported a higher prevalence [11].
The objective of the present multicenter,
international study is to determine the preva-
lence of eyelid disorders in a representative
population of patients presenting for routine
ophthalmic consultations.
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METHODS
Study Design
A cross-sectional epidemiologic survey was per-
formed on patients presenting for routine oph-
thalmologic consultations at clinics or hospitals
in Belgium, Denmark, France, Germany, The
Netherlands, Poland, Portugal, Russia, Spain,
Turkey, and Ukraine.
Subjects
Participating ophthalmologists were required to
recruit at least ten consecutive patients pre-
senting to their clinic regardless of the reason
for the consultation. Adult patients aged 18–-
99 years were included in this study. There were
no specific exclusion criteria other than inabil-
ity or unwillingness to give informed consent.
Recruitment of Investigators
Ophthalmologists were identified from national
databases and the numbers included per coun-
try adjusted to maintain proportionality. The
first 349 qualifying ophthalmologists who
agreed to participate in the study were selected
to recruit patients.
Study Setting
The study was conducted in the context of a
routine ophthalmic patient visit.
Ethical Considerations
The guidelines of Good Epidemiological Prac-
tice were followed, and this study conformed to
the principles of the Declaration of Helsinki
[12]. The International Conference of Harmo-
nization (ICH) rules were not applicable as no
patient interventions or management was per-
formed specifically for this study.
Approval from local or national ethics com-
mittees was obtained according to the regula-
tions in each country [France: Comite´
consultatif sur le traitement de l’information en
matie`re de recherche (C.C.T.I.R.S.); Ukraine:
Ethics Committees at Medical Centre ‘‘Eurozir’’
(Zaporizhzya), at LLC ‘‘Vzgliad’’ MC’’
(Dnipropetrovsk), at Pyrogov Vinnytsya Regio-
nal Clinical Hospital (Vinnytsya), at the Centre
of Modern Ophthalmology ‘‘Your Vision’’ (Ch-
ernivtsi), at LLC ‘‘Polymed Zakhid’’ (Lviv), at PI
‘‘Regional Clinical Hospital-Centre of Emer-
gency Medical Care and Disaster Medicine’’*
(Kharkiv), at MI ‘‘City Polyclinic No. 29’’
(Odessa); Poland: Komiska Etyki Lubelska Izba
Lekarska (Lublin); Spain: Comite´ e´tico de
investigacio´n clı´nica (Madrid); Belgium: Comite´
Local d’Ethique Hospitalier CHU Saint-Pierre
(Brussels); Russia: Independent Interdisciplinary
Committee for the Ethical Examination of
Clinical Research (Moscow); Turkey: Ministry of
Health (Tu¨rkiye Cumhuriyeti Sag˘lık Bakanlıg˘ı);
The Netherlands: not subject to Medical
Research Involving Human Subjects Act and
ethics review (Rotterdam); German: Ethics
Committees of the German Medical Association
‘Landesa¨rztekammer’ (Baden-Wu¨rttemberg,
Bayern, Brandenburg, Hessen, Rheinland-Pfalz,
Sachsen) and ‘A¨rztekammer’ (Berlin, Bremen,
Hamburg, Niedersachsen, Nordrhein, Saarland,
Schleswig-Holstein, Westfalen-Lippe). There
was no regulatory process required for other
countries because this was an observational
study.] This study required no additional
investigations, outside of those normally per-
formed for a routine ophthalmologic consulta-
tion or required by clinical findings during the
consultation.
Prior to data collection, all patients under-
went a thorough informed consent procedure
that explained the nature and purpose of the
study and the use of their data. Approval from
data protection organizations was not required
because no direct or indirect personally identi-
fiable data were collected.
Primary Objective
The primary objective of the study was to
determine the prevalence of eyelid disorders in
a population of general ophthalmology
patients.
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Secondary Objectives
Secondary objectives were to evaluate for asso-
ciations between eyelid disorders and ocular
surface pathology, to assess the impact of eyelid
disorders on patient quality of life and to
determine the current strategy among oph-
thalmologists for treating eyelid disorders in
routine practice.
Procedure
During the course of ophthalmic consultation,
the investigator completed a questionnaire for
each patient enrolled in the study. An ocular
surface examination was also performed. Tests
such as Schirmer’s test, tear break-up time and
slit-lamp examination were performed as clini-
cally warranted. Data were collected on the
impact of ocular symptoms on the daily living
activities of the patients. The intended man-
agement plan was noted for any pathology
identified during the consultation.
Clinical Examinations
Eyelid and Meibomian Gland Examination
A patient was diagnosed with an eyelid disorder
if at least one of the following clinical signs
were present: abnormal position of eyelids (en-
tropion, ectropion, floppy eyelids); abnormal
eyelashes (sparse, trichiasis, distichiasis,
madarosis, cylindrical dandruff); abnormal
eyelid margin (desquamation and crusting,
telangiectasia, thickening, irregularities, whit-
ish foam, fatty secretions, pigmentation,
inflammation/swelling, meibomian gland
obstruction); unclear secretions with pressure
was applied to the meibomian gland (cloudy
secretion, toothpaste-type secretion, secretion
not expressed); miscellaneous abnormalities
such as stye, chalazion and concretions.
Ocular Surface Examination
The ocular surface was examined, and a slit-
lamp examination with staining was performed
if clinically required. Investigators specifically
noted the presence of hyperemia, follicles,
papillae and concretions. Corneal examination
was performed with specific reference to ulcer-
ation, filaments, superficial punctate keratitis
and pannus.
Schirmer’s Test and Tear Break-Up Time
Schirmer’s test and tear break-up time were
performed according to the clinician’s normal
practice and clinical need. Schirmer’s test was
scored as normal or abnormal (\10 mm in
5 min). Tear break-up time was scored as normal
or abnormal (\10 s).
Symptoms
The questionnaire included specific queries on
the presence of red eye; burning/stinging sen-
sation; irritation with foreign body sensation;
itching; tearing in the morning or during the
day; dry eye sensation; sensitivity to light; dry,
rough eyelid skin; discomfort on opening and
closing eyelids; blurred vision. These signs and
symptoms were rated on a 4-point scale as fol-
lows: 0 = none; 1 = present but not disturbing;
2 = disturbing; 3 = very disturbing.
Questionnaire items also recorded the degree
of impact of symptoms on vision, daily activi-
ties and work, leisure, use of contact lenses,
emotions and sleep. The degree of impact was
scored as slight, moderate or severe.
Statistical Methods
Sample size calculations estimated an expected
prevalence of eyelid disorders of 60–70% and a
target precision of about 4%. Power calculations
suggested that 539 patients were required for
the primary variable. However, ten classes of
ocular history were being considered in this
study (rosacea, atopic dermatitis, seborrheic
dermatitis, dry eye, age-related macular degen-
eration, glaucoma, diabetes, cataract, allergy
and MGD); hence, a patient sample size of
approximately 5390 was planned. Each investi-
gator was required to enroll 10 consecutive
patients, and a 20% rate of inactivity or under-
enrollment by investigators led to a target of
recruiting 647 ophthalmologists.
Statistical associations were evaluated for the
incidence of MGD and the presence of eyelid
disorders, clinical signs of eyelid disorders and
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ocular surface disorders. The chi-square test or
Fischer’s exact test were used as appropriate. P\
0.05 was considered statistically significant.
RESULTS
Patient Population
A total of 349 investigators were recruited, and
6660 patients were enrolled. Data from 6525
patients were used in the final analysis. One
hundred thirty-five patients did not meet the
inclusion criteria and were excluded from the
analysis.
The largest numbers of ophthalmologists
and patients were recruited in Poland and
Spain. The majority of ophthalmologists
involved in the study described themselves as
general ophthalmologists. The mean patient
age was 57.0 ± 17.6 years, and 61.6% of
patients were female (Table 1).
Ocular History
Prior ocular history was reported in 79.2% of
patients and included dry eye in 30% of
patients, followed by 27.2% of patients with
cataract, 18.1% with ocular manifestations of
diabetes, 16.3% with glaucoma, 15.1% with
MGD, 12.7% with allergy and 10.9% with age-
related macular degeneration.
Prevalence of Eyelid Disorders
Eyelid disorders were present in 78.3% [95%
confidence interval (CI) 77.3–79.3%] of
patients. There was a statistically significant
association between eyelid disorders and rosa-
cea, atopic dermatitis, seborrheic dermatitis, dry
eye, age-related macular degeneration, diabetes,
cataract, allergy and MGD (P\ 0.02, Fischer’s
exact test or chi-squared test, all associations).
Eyelid disorders were statistically signifi-
cantly associated with the presence of the fol-
lowing subjective symptoms: red eye, burning/
stinging sensation, irritation with foreign body
sensation, itching; tearing in the morning or
during the day, sensation of dry eye, sensitivity
to light, dry, rough eyelid skin, discomfort on
opening and closing eyelids and blurred vision
(P\0.001, Fischer’s exact test or chi-squared
test, all associations). Dry and rough eyelid skin
was the most common subjective symptom
associated with the presence of eyelid disorders
(93%). Several other subjective symptoms were
associated with eyelid disorders at rates[80%.
External Appearance of Eyelids
Examination indicated 50% of patients with
abnormal appearance of the periocular skin,
predominantly redness (19.3% of patients) and
oily (10.9% of patients) or dry skin (13.1% of
patients); 12.3% of patients had an abnormal lid
position, such as floppy eyelids (8.5% of
patients), ectropion (2.5% of patients) or
entropion (1.3% of patients). Twenty-seven
percent of patients had an abnormal appear-
ance of the eyelashes.
Eyelid Margin and Meibomian Gland
Examination
The eyelid margin was abnormal in 59.6% of
patients. Lid margin abnormalities included,
telangiectasia in 36.9% of patients, thickening
in 37.1% and meibomian gland obstruction in
31.3%. Pressure on the glands produced cloudy
Table 1 Demographic Characteristics of Patients Pre-
senting for a Routine Ophthalmic Visit
Age (years) (N = 6335 patients)
Mean ± SD 57.0 ± 17.6
Min; max 18;99
Gender (N = 6292 patients)
Male n (%) 2414 (38.4%)
Female n (%) 3878 (61.6%)
Contact lenses wearers (N = 5753 patients)
Yes n (%) 645 (11.2%)
No n (%) 5108 (88.8%)
N number of patients, SD standard deviation
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secretion in 26.1% of patients, toothpaste-type
secretions in 8.7% of patients and no secretions
in 26.1% of patients. Stye, chalazion and con-
cretions were noted in 4–5% of patients.
Ocular Surface Examination
Abnormal conjunctiva was noted in 64.9% of
patients (Table 3). Hyperaemia was the most
common conjunctival abnormality (87.8%)
(Table 3); 28.1% of patients had corneal abnor-
malities (Table 3). Superficial punctate keratitis
was the most common corneal abnormality
(Table 3). An abnormal tear break-up time was
noted in 50.5% of patients, and an abnormal
Schirmer’s test was noted in 37.0% (Table 2).
Overall Diagnosis
Dry eye was diagnosed in 61.8% of patients.
Ocular surface disorders such as allergic con-
junctivitis and infectious conjunctivitis were
diagnosed in 9.9% and 4% of patients, respec-
tively. The majority (74.6%) of patients with an
abnormal tear break-up time had concurrent
MGD.
MGD was diagnosed in 54.3% of patients. Of
these patients, 37.6% had hyposecretory MGD,
36.9% had obstructive MGD and 37.2% had
hypersecretory MGD. Hyposecretory MGD was
predominantly primary in nature (74. %) as
were cicatricial (76.6%) and non-cicatricial
(60%) MGD. Secondary cases of hypo- and
hypersecretory MGD were most frequently due
to seborrheic dermatitis, acne rosacea or atopy.
Secondary cases of cicatricial obstructive MGD
were most commonly due to atopy, ocular
pemphigoid or trachoma.
The diagnosis of MGD was statistically sig-
nificantly associated with eyelid disorders, eye-
lid margin abnormality and conjunctival
hyperaemia (P\ 0.001, all associations). MGD
was not associated with superficial punctate
keratitis. There was a statistically significant
association between MGD and dry eye
(P\0.001). Among patients diagnosed with
either MGD or dry eye, 67.6% had concurrent
MGD and dry eye (Table 3).
Patient-Reported Incidence and Severity
of Dry Eye Symptoms
Figure 1 presents the patient-reported severity
of dry eye symptoms. Forty percent of patients
found the burning/stinging sensation dis-
turbing or very disturbing (Fig. 1). Foreign body
Table 2 Ocular surface examination of patients presenting
for a routine ophthalmic visit
Parameter Value
Conjunctival examination N = 6473
Normal 35.1%
Abnormal 64.9%
Type of conjunctival abnormality N = 4201
Papillae 13.2%
Conjunctival hyperemia 87.8%
Fluorescein staining 14.0%
Follicles 13.1%
Concretions 8.0%
Corneal examination N = 6405
Normal 71.9%
Abnormal 28.1%
Type of corneal abnormality N = 1801
Superficial punctate keratitis (fluorescein) 81.0%
Ulceration 6.2%
Pannus 9.8%
Filaments 14.5%
Tear film examination
Break-up time N = 5527
Normal 49.5%
Abnormal (\ 10 s) 50.5%
Schirmer’s test N = 4758
Normal 63.0%
Abnormal (\ 10 mm in 5 min) 37.0%
Some patients had concurrent conjunctival or corneal
abnormalities
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sensation, sensation of dry eye and tearing were
reported as disturbing or very disturbing in
36.6%, 32.7% and 30.1% of patients,
respectively.
Impact of Eyelid Disorders on Daily Life
Figure 2 presents the patient-reported impact of
lid disorders on daily life activities. Vision was
impaired in more than half of all patients, as
were daily activities and work (Fig. 2). Approxi-
mately 20% of patients had slight to strongly
impaired emotion and or sleep (Fig. 2). Impacts
on all domains were statistically significantly
associated with the presence of MGD
(P\0.001, all associations). Among contact
lens wearers, 8.6% had to remove them because
of strong impairment (indicating the significant
impact of eyelid disorders on the quality of life).
Table 3 Comparison of the proportion of meibomian gland dysfunction in dry eye patients
Dry eye MGD
Yes (n = 2968) (%) No (n = 2633) (%)
Yes (n = 3360) 67.6 32.4
No (n = 2241) 32.8 67.2
Fig. 1 Prevalence and severity of dry eye symptoms among
patients presenting for a routine ophthalmic visit. Patients
were queried regarding their experience of each symptom
and asked to rate them on a 3-point scale as follows:
0 = none, 1 = present but not disturbing, 2 = disturbing,
3 = very disturbing
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Treatment of Eyelid Disorder
Tear substitutes were the most frequently pre-
scribed drugs (77.4%). The most common pre-
scriptions were viscous solutions or a
combination of viscous solution and another
type of eye drop. The mean number of instilla-
tions was 4.8 ± 2.6 per day. A prescription for
topical lubricants was statistically significantly
associated with a diagnosis of dry eye and MGD
(both P\0.001). Eyelid hygiene recommenda-
tions included warming for 40.9% of patients
with eyelid disorder, eyelid cleansing for 59.2%
and ocular massage for 44.8% of patients.
Omega-3 fatty acids and vitamins were recom-
mended for 81.1% and 62.2% of patients,
respectively, who were given dietary advice.
Nutritional recommendation (enhanced con-
sumption of omega-3 fatty acids and vitamins)
was proposed for the majority of patients
regardless of their diagnosis.
DISCUSSION
The outcomes of this multicenter European
study indicate a high prevalence of dry eye and
eyelid disorders. Regional prevalence data are
Fig. 2 Impact of eyelid disorders on daily life. Patients
were questioned about the impact of eyelid disorders on
their various aspects of daily life activities and the degree of
impairment of each activity (slight, moderate or severe).
N = 4859 patients with eyelid disorders
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important because of the widely varying ranges
reported in the literature [11]. For example,
prevalence of MGD has been reported as\10%
in Caucasians to[60% in Japanese and Chinese
populations [11]. Hence, the geographic area
likely plays a role in the prevalence of dry eye
and MGD. The prevalence of MGD in the cur-
rent study (54%) was higher than that reported
in a similar study of 120 ophthalmologists [13].
Lemp and colleagues estimated that 37% of
their patients presented with some form of
blepharitis, and dry eye was the most common
reason that patients sought treatment [13].
Hom and colleagues used similar methods to
the current study and reported a prevalence of
39% for MGD [14]. The differences in size of the
study sample and the geographic locale may
explain the difference in prevalence between
our study and previous studies [13, 14].
Population-based epidemiologic studies have
reported prevalences of dry eye up to 34% based
on geographic locale [15]. It is not surprising
that the prevalence of dry eye in a population
presenting for ophthalmologic consultation is
higher than that in the population at large.
Patients with constant signs and symptoms due
to dry eye are more likely to self-select to eye
clinics.
We believe that the prevalence of dry eye is
likely to increase over time because of demo-
graphic pressures from an aging population and
environmental and lifestyle changes (e.g., air-
conditioning, pollution and increased use of
digital devices). In the current study almost
78.3% of all patients presented with some type
of eyelid disorder, and [ 50% were diagnosed
with MGD. Additionally, 50.5% of patients had
an abnormal tear break-up time. Abnormalities
of the eyelid, cornea and conjunctiva were also
common. The presence of MGD was statistically
significantly associated with eyelid disorders,
eyelid margin abnormalities and conjunctival
hyperaemia (P\0.05).
The patient survey from the current study
indicates that eyelid disorders have a statisti-
cally significant impact on patient-related
quality of life, particularly in terms of impair-
ment in vision and daily activities/work. Addi-
tionally, impacts were reported on mood and
quality of sleep. The impact of dry eye on
patient psychology may be warranted in future
studies as an association between psychologic
stress and dry eye has been previously reported
[16, 17]. Studies of medical students and para-
medics indicate that increased stress resulted in
a greater risk of dry eye disease [16, 17].
Caution is urged in generalizing these results
to the population at large. Patients presenting
to an ophthalmologist are likely to be at a
higher risk of dry eye and eyelid disorders. Some
may be proactively seeking consultation for
these conditions. Others may receive a diagno-
sis of dry eye/eyelid disorders in addition to the
diagnosis from their presenting complaint. For
example, management of glaucoma represents a
considerable proportion of a general ophthal-
mologist’s workload, and glaucoma patients are
known to have a greater risk for ocular surface
disorders [18, 19]. Glaucoma patients and other
general ophthalmology patients are more likely
than the general population to be using topical
medications, many of which contain preserva-
tives that are toxic to the ocular surface [20, 21].
Our subjective clinical impression is that glau-
coma patients on topical therapy often com-
plain of stinging and burning on instillation of
anti-glaucoma medications. Aggressive treat-
ment of a suboptimal ocular surface in these
patients may increase patient compliance.
Hence, although the outcomes of the current
study are likely valid for a population of
patients presenting to a general ophthalmology
clinic, they may not be indicative of the general
population. Notably, the outcomes of the cur-
rent study do not indicate a significant associ-
ation between having glaucoma and eyelid
disorders, likely because of poor generalizability
to the population at large.
Dry eye, MGD and eyelid abnormalities form
a constellation of associated disorders that are
likely to increase because of several factors. The
prevalence of dry eye and glaucoma increases in
older populations [22, 23]. The prevalence of
type 2 diabetes is also age-related and associated
with a higher risk of dry eye [24, 25]. Lid laxity
due to floppy eyelid syndrome or due to surgery
is associated with evaporative dry eye [26, 27].
Poor lid apposition results in ocular surface
dessication [26]. Floppy eyelid syndrome is
associated with obesity, and given the
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increasing incidence of obesity, there will like a
concomitant increase in the incidence of floppy
eyelid syndrome and dry eye [26, 28].
There are some limitations to this study
including those inherent to a cross-section
study design. This study design precludes any
causal inferences between the associations
reported here as the order of the variables and
disease cannot be established (e.g., eyelid dis-
order or MGD or vice versa). Additionally, some
major factors associated with eyelid disorders
were not evaluated in this study. Individuals
who use digital display terminals for long peri-
ods or those who work in a dusty environment
are at greater risk for dry eye [7, 29]. For exam-
ple, a significant decrease in tear film break-up
time was reported among patients subjected to
airborne dust in a climate chamber [29].
CONCLUSION
In summary, this study confirms a high preva-
lence of dry eye, MGD and associated ocular
surface disorders in a population of patients
presenting for a routine ophthalmologic
assessment. However, the prevalence in this
population is likely to be higher than in the
general population. The findings of this study
suggest that these disorders are underdiagnosed,
and the majority (perhaps all) of patients
require assessment for dry eye, MGD and ocular
surface disease. Timely diagnosis and appropri-
ate treatment of eyelid disorders and dry eye
present an opportunity to improve patient-re-
lated quality of life and perhaps to improve
their adherence to topical treatment of other
ophthalmic conditions.
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Committees of the German Medical Association
‘Landesa¨rztekammer’ (Baden-Wu¨rttemberg,
Bayern, Brandenburg, Hessen, Rheinland-Pfalz,
Sachsen) and ‘A¨rztekammer’ (Berlin, Bremen,
Hamburg, Niedersachsen, Nordrhein, Saarland,
Schleswig–Holstein, Westfalen-Lippe). There
was no regulatory process required for other
countries because this was an observational
study]. Prior to data collection, all patients
underwent a thorough inform consent proce-
dure that explained the nature and purpose of
the study and the use of their data. Approval
from data protection organizations was not
required because no direct or indirect personally
identifiable data were collected.
Data Availability. The datasets during and/
or analyzed during the current study are not
publicly available because the ethics commit-
tees did not agree to broad sharing of the data
beyond the scope of this study.
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